Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-702X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases ; day:19 ; month:5 ; year:2017 ; pages:1-15
Graefe's archive for clinical and experimental ophthalmology ; (19.5.2017), 1-15
- Schlagwort
-
Augenheilkunde
Augenkrankheit
- Beteiligte Personen und Organisationen
-
Lanzetta, Paolo
Loewenstein, Anat
SpringerLink (Online service)
- DOI
-
10.1007/s00417-017-3647-4
- URN
-
urn:nbn:de:1111-2017052810985
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lanzetta, Paolo
- Loewenstein, Anat
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Case report: heart failure related to intravitreal injection of anti-VEGF
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Case report: heart failure related to intravitreal injection of anti-VEGF
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Case report: heart failure related to intravitreal injection of anti-VEGF
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics